BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6095476)

  • 21. Vasoactive intestinal peptide- and adrenocorticotropin-stimulated adenyl cyclase in cultured adrenal tumor cells: evidence for a specific vasoactive intestinal peptide receptor.
    Birnbaum RS; Alfonzo M; Kowal J
    Endocrinology; 1980 Apr; 106(4):1270-5. PubMed ID: 6244149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amygdaloid D1 receptors are not linked to stimulation of adenylate cyclase.
    Leonard SK; Anderson CM; Lachowicz JE; Schulz DW; Kilts CD; Mailman RB
    Synapse; 2003 Dec; 50(4):320-33. PubMed ID: 14556237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of human pancreatic polypeptide and gastrin by Boots and GIH secretin: in vitro and in vivo studies.
    Meryn S; Bauman WA; Panzer S; Straus E
    Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):1-6. PubMed ID: 3557722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
    Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD
    Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-adrenoceptor-G protein-adenylate cyclase complex in rat hearts with ischemic heart failure produced by coronary artery ligation.
    Yamamoto J; Ohyanagi M; Morita M; Iwasaki T
    J Mol Cell Cardiol; 1994 May; 26(5):617-26. PubMed ID: 8072016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demonstration of beta-2 adrenergic receptors of high coupling efficiency in human neutrophil sonicates.
    Galant SP; Allred SJ
    J Lab Clin Med; 1980 Jul; 96(1):15-23. PubMed ID: 6248606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenosine receptor-adenylate cyclase system in the trout testis: involvement in the regulation of germ cell proliferation.
    Loir M
    Mol Reprod Dev; 2001 Mar; 58(3):307-17. PubMed ID: 11170272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review article: Strategies to determine whether hypergastrinaemia is due to Zollinger-Ellison syndrome rather than a more common benign cause.
    Murugesan SV; Varro A; Pritchard DM
    Aliment Pharmacol Ther; 2009 May; 29(10):1055-68. PubMed ID: 19226290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of calcium and secretin in the diagnosis of gastrinoma (Zollinger-Ellison syndrome).
    Deveney CW; Deveney KS; Jaffe BM; Jones RS; Way LW
    Ann Intern Med; 1977 Dec; 87(6):680-6. PubMed ID: 931203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitivity, specificity and predictive values of the secretin infusion test in the diagnosis of gastrinoma.
    Poynard T; Mignon M; Accary JP; Bonfils S
    Gastroenterol Clin Biol; 1986; 10(6-7):492-6. PubMed ID: 3758593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of secretin on parathyroid hormone and calcium in normal subjects, patients with hyperparathyroidism and patients with gastrinoma.
    Benson L; Lundqvist G; Wide L; Akerström G; Oberg K; Ljunghall S
    Acta Med Scand; 1985; 217(2):205-11. PubMed ID: 3993434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secretin-receptor and secretin-receptor-variant expression in gastrinomas: correlation with clinical and tumoral features and secretin and calcium provocative test results.
    Long SH; Berna MJ; Thill M; Pace A; Pradhan TK; Hoffmann KM; Serrano J; Jensen RT
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4394-402. PubMed ID: 17711922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical usefulness of the secretin provocation test.
    Lamers CB
    J Clin Gastroenterol; 1981 Sep; 3(3):255-9. PubMed ID: 7288118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Selective arterial secretin injection test for localization of gastrinoma].
    Imamura M; Minematsu S; Tobe T; Adachi H; Takahashi K
    Nihon Geka Gakkai Zasshi; 1986 Jun; 87(6):671-9. PubMed ID: 3526120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of four provocative tests for the diagnosis of gastrinoma.
    Romanus ME; Neal JA; Dilley WG; Leight GS; Linehan WM; Santen RJ; Farndon JR; Jones RS; Wells SA
    Ann Surg; 1983 May; 197(5):608-17. PubMed ID: 6847280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zollinger-Ellison syndrome associated with a renal gastrinoma in a child.
    Nord KS; Joshi V; Hanna M; Khademi M; Saad S; Marquis J; Pelzman H; Verner E
    J Pediatr Gastroenterol Nutr; 1986; 5(6):980-6. PubMed ID: 2878987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastrinoma in a mesenteric lymph node.
    Kitagawa M; Hayakawa T; Kondo T; Shibata T; Sakai Y; Ohno H; Nimura Y; Hayakawa N; Kamiya J; Kondo S
    Am J Gastroenterol; 1989 Jun; 84(6):660-2. PubMed ID: 2658553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrin release from dispersed gastrinoma cells: effects of calcium and calcium ionophore (A23187).
    Woltering EA; Ellison EC; O'Dorisio TM; Hitchcock C; Roberts K; Stephens R; Sparks J; Carey LC
    J Surg Res; 1985 Oct; 39(4):331-7. PubMed ID: 3930881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cardiac inotropic response to secretin is lower in genetically obese (fa/fa) than in lean (fa/?) Zucker rats.
    Robberecht P; De Neef P; Camus JC; Waelbroeck M; Fontaine J; Christophe J
    Pflugers Arch; 1983 Aug; 398(3):217-20. PubMed ID: 6314240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of somatostatin analogue (SMS 201-995) on molecular species of gastrin in gastrinoma.
    Campagnolo D; Gower WR; Fabri PJ; Sparks J; Mekhjian HS; O'Dorisio TM; Ellison EC
    Surgery; 1987 Dec; 102(6):982-7. PubMed ID: 2891204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.